4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with endothelin-1 in 1 studies
| Studies (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Trials (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Recent Studies (post-2010) (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 62 | 0 | 14 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y; Wang, Z; Xiao, G; Yin, W; Yu, J; Zeng, H; Zhang, S; Zhang, Y | 1 |
1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and endothelin-1
| Article | Year |
|---|---|
Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
Topics: Benzamides; Blotting, Western; Cell Survival; Cells, Cultured; Coloring Agents; Endothelial Cells; Endothelin-1; Female; Gene Expression; Glucose; Humans; Hypolipidemic Agents; Indicators and Reagents; Oncogene Protein v-akt; Organophosphorus Compounds; Phosphatidylinositol 3-Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetrazolium Salts; Thiazoles; Umbilical Veins; von Willebrand Factor | 2011 |